Overview

Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination

Status:
Unknown status

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Summary

This study will primarily address the question whether the combination of Mitoxantrone therapy with dexrazoxane can reduce cardiotoxic side effects in the treatment of Multiple Sclerosis patients in comparison to Mitoxantrone monotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

PD Dr. Andrew Chan

Treatments:

Dexrazoxane
Mitoxantrone
Razoxane